In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Trinity Biotech Plc ADR (NASDAQ: TRIB) closed at $0.86 in the last session, down -9.11% from day before closing price of $0.94. In other words, the price has decreased by -$9.11 from its previous closing price. On the day, 0.25 million shares were traded. TRIB stock price reached its highest trading level at $0.9398 during the session, while it also had its lowest trading level at $0.8305.
Ratios:
We take a closer look at TRIB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.87 and its Current Ratio is at 1.64.
ROTH Capital reiterated its Buy rating for the stock on July 29, 2015, while the target price for the stock was revised from $22 to $20.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TRIB now has a Market Capitalization of 23633488 and an Enterprise Value of 347372704. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.17. Its current Enterprise Value per Revenue stands at 5.923 whereas that against EBITDA is -30.749.
Stock Price History:
The Beta on a monthly basis for TRIB is 1.03, which has changed by -0.6090909 over the last 52 weeks, in comparison to a change of 0.23806548 over the same period for the S&P500. Over the past 52 weeks, TRIB has reached a high of $3.55, while it has fallen to a 52-week low of $0.75. The 50-Day Moving Average of the stock is -28.36%, while the 200-Day Moving Average is calculated to be -52.91%.
Shares Statistics:
According to the various share statistics, TRIB traded on average about 207.16K shares per day over the past 3-months and 365720 shares per day over the past 10 days. A total of 11.37M shares are outstanding, with a floating share count of 10.96M. Insiders hold about 3.57% of the company’s shares, while institutions hold 23.71% stake in the company. Shares short for TRIB as of 1730332800 were 94129 with a Short Ratio of 0.28, compared to 1727654400 on 100040. Therefore, it implies a Short% of Shares Outstanding of 94129 and a Short% of Float of 2.4300002000000003.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 1.19.
Earnings Estimates
The market rating for Trinity Biotech Plc ADR (TRIB) is a result of the insights provided by 1 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.28, with high estimates of -$0.28 and low estimates of -$0.28.
Analysts are recommending an EPS of between -$1.74 and -$1.74 for the fiscal current year, implying an average EPS of -$1.74. EPS for the following year is -$0.9, with 1.0 analysts recommending between -$0.9 and -$0.9.
Revenue Estimates
For the next quarter, 1 analysts are estimating revenue of $16M. There is a high estimate of $16M for the next quarter, whereas the lowest estimate is $16M.
A total of 1 analysts have provided revenue estimates for TRIB’s current fiscal year. The highest revenue estimate was $62.2M, while the lowest revenue estimate was $62.2M, resulting in an average revenue estimate of $62.2M. In the same quarter a year ago, actual revenue was $56.83MBased on 1 analysts’ estimates, the company’s revenue will be $68.5M in the next fiscal year. The high estimate is $68.5M and the low estimate is $68.5M.
